As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
BenevolentAI is a clinical-stage artificial intelligence company dedicated to transforming biopharmaceutical research and drug discovery. The company leverages proprietary machine learning platforms and deep learning algorithms to analyze complex biomedical data and identify novel disease targets. By accelerating the target-to-clinic pipeline, BenevolentAI develops innovative therapies across oncology, neurology, and inflammatory diseases.
News
Benevolent dictator Zuck will give Meta staff 30-minute breaks from keylogging privacy assault
Tech biz teaching AI to use computers by slurping staff activity
Read more
Report
Creating a Benevolent Industrial Deployer
Industrial token deployers are rent-seeking actors that could be replaced by a protocol, aligning incentives with traders.
Read more
Report
Your creativity is benevolent, and you can always return to it
Scenes from the summer, a new publication, an upcoming reading, a pep talk about returning to yourself
Read more
Report
'Benevolent leadership' enhances organizational learning, study finds
Researchers found that this approach can create the kind of workplace environment that encourages knowledge-sharing.
Read more
Report
